Beyondspring Inc
Beyondspring Inc logo
BYSI

Beyondspring Inc (BYSI)

$0.583.33%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.56
Day's Range
$0.582
$0.5481
52-Week Range
$6.34
1 month return24.25%
3 month return54.33%
1 year return88.24%
5 year return98.16%

Company Information

BeyondSpring is a global, clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies. BeyondSpring's lead asset, plinabulin, a first-in-class agent as an immune and stem cell modulator, is in a Phase 3 global clinical trial as a direct anticancer agent in the treatment of non-small cell lung cancer (NSCLC) and Phase 3 clinical programs in the prevention of CIN. The U.S. FDA granted Breakthrough Therapy designation to plinabulin for concurrent administration with myelosuppressive chemotherapeutic regimens in patients with non-myeloid malignancies for the prevention of chemotherapy-induced neutropenia (CIN). BeyondSpring has strong R&D capabilities with a robust pipeline in addition to plinabulin, including three immuno-oncology assets and a drug discovery platform using the protein degradation pathway, which is being developed in a subsidiary company, Seed Therapeutics, Inc. The Company also has a seasoned management team with many years of experience bringing drugs to the global market. BeyondSpring is headquartered in New York City.
OrganizationBeyondspring Inc
Employees103
CEODr. Lan Huang
IndustryHealth Technology

Analyst Recommendation

based on 6 analysts ratings

Hold
33%
Buy
50%
Hold
16%
Sell

Based on 6 Wall street analysts offering stock ratings for Beyondspring Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 296.55%

Current

$0.58

Target

$2.3

Recommendation Trend

Based on 6 analyst

Current1M Ago3M Ago
Buy
2
0
1
Hold
3
3
5
Sell
1
4
4
Consensus
HOLD
SELL
HOLD

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
22.2M
Book Value
$0.69
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.64
PEG Ratio
0.0
Wall Street Target Price
2.3

Valuation

Trailing PE0.0
Forward PE10.54
Price/Book (mrq)
0.87
Enterprise Value
-45579684
Enterprise Value/Revenue
5.27
Enterprise Value/Ebitda
0.71

Technicals

Beta
0.98
50 Day MA
0.84
200 Day MA
1.51

Institutional Holdings

Millennium Management LLC

1.78%

Renaissance Technologies Corp

0.94%

Citadel Advisors Llc

0.9%

BNP Paribas Arbitrage, SA

0.64%

D. E. Shaw & Co LP

0.42%

Susquehanna International Group, LLP

0.27%

Discover more

Frequently Asked Questions

What is Beyondspring Inc share price today?

Can Indians buy Beyondspring Inc shares?

How can I buy Beyondspring Inc shares from India?

Can Fractional shares of Beyondspring Inc be purchased?

What are the documents required to start investing in Beyondspring Inc stocks?

What are today’s High and Low prices of Beyondspring Inc?

What are today’s traded volumes of Beyondspring Inc?

What is today’s market capitalisation of Beyondspring Inc?

What is the 52 Week High and Low Range of Beyondspring Inc?

How much percentage Beyondspring Inc is down from its 52 Week High?

How much percentage Beyondspring Inc is up from its 52 Week low?

What are the historical returns of Beyondspring Inc?

Who is the Chief Executive Officer (CEO) of Beyondspring Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*